DrugCard is an AI-enabled tool that specializes in local literature screening for the pharmaceutical industry. It is designed to streamline drug safety routines and ensure compliance with regulatory requirements. The tool offers continuous and regular screening, allowing pharmaceutical companies to stay up-to-date with the latest literature in their local markets. It provides traceability and transparency, allowing users to track the screening process and ensuring that it is accurate, complete, and holistic.DrugCard is scalable to new markets, making it suitable for companies looking to expand their operations globally. It enables CROs to manage more projects and improve screening results, while MAHs can choose to perform in-house screening to mitigate compliance and reputation risks. Freelancers can also benefit from the tool by saving time on literature screening and focusing on other value-adding activities.Overall, DrugCard offers a reliable and efficient solution for local literature screening, providing the pharmaceutical industry with the necessary tools to streamline drug safety processes and meet regulatory requirements.
AI-Powered Literature Monitoring: Automates global and local medical literature monitoring, enhancing efficiency and reducing manual search efforts for pharmacovigilance teams.
Comprehensive Coverage: Monitors over 2,200 local journals across 127 countries, providing tailored source lists and quick addition of new journals.
Real-Time Documentation and Traceability: Automatically records all activities and screening steps, ensuring full visibility and audit readiness without manual paperwork.
AI-Driven Features: Includes AI-generated article summaries, pre-assessment of safety relevance, and automatic translation of local sources to streamline the review process.
User-Friendly Search Interface: Allows users to filter searches by keywords, date range, and country, with AI-generated abstracts for easier access to relevant safety information.
Automates local and global medical literature monitoring to enhance pharmacovigilance processes.
Provides a simple search interface for accessing local journals with AI-generated abstracts, improving efficiency in finding relevant safety information.
Offers real-time notifications and weekly reports on new findings, ensuring continuous oversight and compliance.
Maintains a comprehensive audit trail and documentation of all screening actions, facilitating easier preparation for regulatory inspections.
Supports various pharmacovigilance services, including signal management, risk management plans, and training, to enhance overall drug safety operations.
Automates local and global literature monitoring, significantly reducing the time spent on manual searches.
Enhances compliance by providing a structured, traceable workflow that is audit-ready.
Increases accuracy in identifying relevant safety information through advanced keyword detection and AI-generated summaries.
Centralizes documentation and monitoring processes, making it easier to manage and present data during audits.
Frees up pharmacovigilance specialists to focus on critical tasks such as signal detection and risk assessment, improving overall productivity.
DrugCard offers a free 2-week trial for new users to experience the platform's benefits.
The platform supports over 100 languages and monitors 2,200+ local journals across 127 countries.
Users can save approximately 60% of time compared to a human-only approach to literature screening.
DrugCard provides automated literature monitoring, eliminating manual searches and ensuring compliance.
The platform is designed to be audit-ready, maintaining a clear audit trail and documentation of all activities.
